In this week’s roundup, Unilever implement a 4-day week, Café Nero reject a takeover bid from Issa Brother and ASDA help feed children during these troubled times.
Category: FMCG News
Drinks group Diageo is recalling all its newly launched non-alcoholic paddy power stout because of a ‘microbiological contamination’, only two weeks after it was launched.
It warned that cans of the new Guinness 0.0 drink, which took four years to develop, may be ‘unsafe to consume’ and advised people who had purchased the alcohol-free beer to dispose of it or return it to where it was bought.
‘It warned that cans of the new Guinness 0.0 drink, which took four years to develop, may be ‘unsafe to consume’ ‘
The contamination is understood to have occurred during the production process at its St James’s Gate brewery in Dublin and tests are being carried out to establish the cause. In the meantime, production and canning has been halted.
Guinness 0.0 went on sale at the end of October this year in 4x440ml can packs in off-licences and in Waitrose and Morrison’s supermarkets, with plans for it to be rolled out to other retailers. It was due to become available on draught in pubs next spring and to be launched in other parts of the world later in 2021.
The new drink was launched to tap into consumers’ growing appetite for non- and low-alcohol options. Even before lockdown, an increasing number of brewers were offering more no- and low-alcohol alternatives, while COVID-19 related restrictions have increased consumers’ thirst for hangover-free options as drinking habits have become home-based.
It seems that this issue is isolated to Guinness 0.0 and does not impact any other Guinness variants or brands. However, if you have bought Guinness 0.0 and have a few cans stacked up in the fridge or stored in the backroom, do not consume it.
It’s been all over the news; we may have a cure.
The first effective coronavirus vaccine has been developed and it looks like it can prevent more than 90% of people from getting COVID-19. The developers – Pfizer and BioNTech – described it as a ‘great day for science and humanity’. Their vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised. The companies plan to apply for emergency approval to use the vaccine by the end of the month.
‘The two companies say they will be able to supply 50 million doses by the end of this year and around 1.3 billion by the end of 2021. ‘
No vaccine has gone from the drawing board to being proven highly effective in such a short period of time, ever. There are still huge challenges ahead, but the announcement has been warmly welcomed with scientists describing themselves smiling ‘ear to ear’ and some suggesting life could be back to normal by spring.
Pfizer and BioNTech say they will have enough safety data by the third week of November to take their vaccine to regulators. Until it has been approved it will not be possible for countries to begin their vaccination campaigns. The two companies say they will be able to supply 50 million doses by the end of this year and around 1.3 billion by the end of 2021. Each person needs two doses. The UK should get 10 million doses by the end of the year, with a further 30 million doses already ordered.
The COVID-19 pandemic is having a significant impact on business across the globe, including FMCG and retail – so this will be very welcome news for us all. The pandemic is leading to a recession in many countries and retailers the world over are feeling the pinch the pandemic has caused.
If it is the case that a vaccine will bring things back to normal by spring, then the FMCG industry will be more grateful than many (but perhaps not as grateful as airlines) that this period of economic uncertainty is coming to an end.